ID   AA2AR_RAT               Reviewed;         410 AA.
AC   P30543;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   10-FEB-2021, entry version 173.
DE   RecName: Full=Adenosine receptor A2a;
GN   Name=Adora2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=1599465; DOI=10.1016/s0006-291x(05)90000-4;
RA   Chern Y., King K., Lai H.-L., Lai H.-T.;
RT   "Molecular cloning of a novel adenosine receptor gene from rat brain.";
RL   Biochem. Biophys. Res. Commun. 185:304-309(1992).
RN   [2]
RP   SEQUENCE REVISION TO 183.
RC   TISSUE=Brain;
RA   Chern Y.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Corpus striatum;
RX   PubMed=1279342; DOI=10.1016/0169-328x(92)90173-9;
RA   Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E.,
RA   Adler E.M., Reppert S.M.;
RT   "Molecular cloning of the rat A2 adenosine receptor: selective co-
RT   expression with D2 dopamine receptors in rat striatum.";
RL   Brain Res. Mol. Brain Res. 14:186-195(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yip L., Hewitt J., Kwok Y.;
RT   "Rattus norvegicus mucosa A2A adenosine receptor mRNA.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16339847; DOI=10.1124/mol.105.015818;
RA   Milojevic T., Reiterer V., Stefan E., Korkhov V.M., Dorostkar M.M.,
RA   Ducza E., Ogris E., Boehm S., Freissmuth M., Nanoff C.;
RT   "The ubiquitin-specific protease Usp4 regulates the cell surface level of
RT   the A2A receptor.";
RL   Mol. Pharmacol. 69:1083-1094(2006).
RN   [7]
RP   FUNCTION, INTERACTION WITH GAS2L2, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=23994616; DOI=10.1016/j.bbamcr.2013.08.009;
RA   Wu Y.C., Lai H.L., Chang W.C., Lin J.T., Liu Y.J., Chern Y.;
RT   "A novel Galphas-binding protein, Gas-2 like 2, facilitates the signaling
RT   of the A2A adenosine receptor.";
RL   Biochim. Biophys. Acta 1833:3145-3154(2013).
CC   -!- FUNCTION: Receptor for adenosine (By similarity). The activity of this
CC       receptor is mediated by G proteins which activate adenylyl cyclase
CC       (PubMed:23994616). {ECO:0000250|UniProtKB:P11617,
CC       ECO:0000269|PubMed:23994616}.
CC   -!- SUBUNIT: Interacts (via cytoplasmic C-terminal domain) with USP4; the
CC       interaction is direct (By similarity). May interact with DRD4 (By
CC       similarity). Interacts with NECAB2 (By similarity). Interacts (via
CC       cytoplasmic C-terminal domain) with GAS2L2; interaction enhances
CC       receptor-mediated adenylyl cyclase activity (PubMed:23994616).
CC       {ECO:0000250|UniProtKB:P29274, ECO:0000269|PubMed:23994616}.
CC   -!- INTERACTION:
CC       P30543; P20272: Cnr1; NbExp=3; IntAct=EBI-2902822, EBI-2909800;
CC       P30543; Q9QZE7: Tsnax; Xeno; NbExp=6; IntAct=EBI-2902822, EBI-2910751;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16339847,
CC       ECO:0000269|PubMed:23994616}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:16339847}. Note=Colocalizes with GAS2L2 at neuronal
CC       processes. {ECO:0000269|PubMed:23994616}.
CC   -!- TISSUE SPECIFICITY: Expressed in striatal neurons (at protein level).
CC       {ECO:0000269|PubMed:23994616}.
CC   -!- DOMAIN: The cytoplasmic C-terminal domain is necessary for targeting
CC       the non-ubiquitinated form of this protein to the cell surface.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Deubiquitinated by USP4; leading to stabilization
CC       and expression at the cell surface (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M91214; AAA70305.2; -; mRNA.
DR   EMBL; L08102; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; S47609; AAA11888.1; -; mRNA.
DR   EMBL; AF228684; AAF61924.1; -; mRNA.
DR   EMBL; BC081727; AAH81727.1; -; mRNA.
DR   PIR; A48974; A48974.
DR   RefSeq; NP_445746.3; NM_053294.4.
DR   RefSeq; XP_017457041.1; XM_017601552.1.
DR   RefSeq; XP_017457042.1; XM_017601553.1.
DR   RefSeq; XP_017457043.1; XM_017601554.1.
DR   RefSeq; XP_017457044.1; XM_017601555.1.
DR   SMR; P30543; -.
DR   BioGRID; 247408; 5.
DR   IntAct; P30543; 7.
DR   STRING; 10116.ENSRNOP00000001759; -.
DR   BindingDB; P30543; -.
DR   ChEMBL; CHEMBL302; -.
DR   DrugCentral; P30543; -.
DR   GuidetoPHARMACOLOGY; 19; -.
DR   GlyGen; P30543; 2 sites.
DR   PhosphoSitePlus; P30543; -.
DR   PaxDb; P30543; -.
DR   Ensembl; ENSRNOT00000001759; ENSRNOP00000001759; ENSRNOG00000001302.
DR   GeneID; 25369; -.
DR   KEGG; rno:25369; -.
DR   UCSC; RGD:2049; rat.
DR   CTD; 135; -.
DR   RGD; 2049; Adora2a.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00990000203617; -.
DR   HOGENOM; CLU_009579_11_5_1; -.
DR   InParanoid; P30543; -.
DR   OMA; IHRDPEK; -.
DR   OrthoDB; 550297at2759; -.
DR   PhylomeDB; P30543; -.
DR   TreeFam; TF325296; -.
DR   Reactome; R-RNO-417973; Adenosine P1 receptors.
DR   Reactome; R-RNO-5683826; Surfactant metabolism.
DR   PRO; PR:P30543; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000001302; Expressed in brain and 20 other tissues.
DR   Genevisible; P30543; RN.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0030673; C:axolemma; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0012505; C:endomembrane system; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; IDA:SynGO-UCL.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; IDA:SynGO-UCL.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0051393; F:alpha-actinin binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0001609; F:G protein-coupled adenosine receptor activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0048143; P:astrocyte activation; IMP:RGD.
DR   GO; GO:0042755; P:eating behavior; IMP:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IDA:RGD.
DR   GO; GO:0001973; P:G protein-coupled adenosine receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; IMP:RGD.
DR   GO; GO:0051899; P:membrane depolarization; IMP:RGD.
DR   GO; GO:0046636; P:negative regulation of alpha-beta T cell activation; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0040013; P:negative regulation of locomotion; IDA:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:RGD.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:RGD.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; IMP:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IDA:RGD.
DR   GO; GO:0014057; P:positive regulation of acetylcholine secretion, neurotransmission; IMP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045938; P:positive regulation of circadian sleep/wake cycle, sleep; IDA:RGD.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IDA:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IDA:RGD.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; IDA:RGD.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IDA:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; IMP:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; IMP:RGD.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:RGD.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IDA:RGD.
DR   GO; GO:0014061; P:regulation of norepinephrine secretion; IMP:RGD.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IDA:SynGO.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:RGD.
DR   GO; GO:0043279; P:response to alkaloid; IMP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; ISO:RGD.
DR   GO; GO:0031000; P:response to caffeine; IDA:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IMP:RGD.
DR   GO; GO:0001963; P:synaptic transmission, dopaminergic; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IDA:RGD.
DR   GO; GO:0042311; P:vasodilation; IMP:RGD.
DR   InterPro; IPR001513; Adeno_A2A_rcpt.
DR   InterPro; IPR001634; Adenosn_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00553; ADENOSINA2AR.
DR   PRINTS; PR00424; ADENOSINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..410
FT                   /note="Adenosine receptor A2a"
FT                   /id="PRO_0000069001"
FT   TOPO_DOM        1..4
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        5..29
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        30..39
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        40..63
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        64..74
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        75..97
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        98..117
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        118..140
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        141..168
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        169..193
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        194..229
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        230..253
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        254..261
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        262..285
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        286..410
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          163..172
FT                   /note="Agonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          241..248
FT                   /note="Agonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          259..269
FT                   /note="Agonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          322..410
FT                   /note="Interaction with GAS2L2"
FT                   /evidence="ECO:0000269|PubMed:23994616"
FT   CARBOHYD        142
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        149
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        68..154
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        71..143
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        74..161
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        254..257
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        268
FT                   /note="A -> T (in Ref. 1; AAA70305)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   410 AA;  44999 MW;  D87B256CD2336BAC CRC64;
     MGSSVYITVE LAIAVLAILG NVLVCWAVWI NSNLQNVTNF FVVSLAAADI AVGVLAIPFA
     ITISTGFCAA CHGCLFFACF VLVLTQSSIF SLLAIAIDRY IAIRIPLRYN GLVTGVRAKG
     IIAICWVLSF AIGLTPMLGW NNCSQKDGNS TKTCGEGRVT CLFEDVVPMN YMVYYNFFAF
     VLLPLLLMLA IYLRIFLAAR RQLKQMESQP LPGERTRSTL QKEVHAAKSL AIIVGLFALC
     WLPLHIINCF TFFCSTCRHA PPWLMYLAII LSHSNSVVNP FIYAYRIREF RQTFRKIIRT
     HVLRRQEPFQ AGGSSAWALA AHSTEGEQVS LRLNGHPLGV WANGSATHSG RRPNGYTLGL
     GGGGSAQGSP RDVELPTQER QEGQEHPGLR GHLVQARVGA SSWSSEFAPS
//
